Cullinan Therapeutics’ strong financial position funds growth into 2028. Find out why CGEM stock presents a compelling buy ...

Despite the widebody makeover and new Vossen alloys, this pre-facelifted Rolls-Royce Cullinan is still very appealing. Dig ...

Rolls-Royce has announced the sales results for 2024 alongside a £300 million ($373 million) investment for the expansion of ...

Those involved with England at the 2003 World Cup will feel a sense of unease at history repeating itself as the pressure ...

Best Buy will move out of its long time location in Peoria and move to The Levee District in East Peoria, Cullinan Properties ...

East Peoria's Levee District is one of the Peoria region's busier hubs for retail and dining and is also the location for a ...

Iconic car brand Jaguar underwent an extensive rebrand in November, changing its logo by removing the famous pouncing cat and ...

Rolls-Royce ( BMW.DE) CEO Chris Brownridge, like many other importers, is wary of President-elect Donald Trump's plans to ...

Shell has determined that an oil discovery off the coast of Namibia is not commercially viable, leading to a projected ...

The biotech will stop developing two drugs and lay off nearly three-quarters of its staff after its lead therapy wasn’t as potent in early testing as the company expected.

Rolls-Royce is investing 300 million pounds (about $376 million USD) to expand its Goodwood plant and focus on bespoke cars ...

CLN-619 is under clinical development by Cullinan Therapeutics and currently in Phase I for Relapsed Multiple Myeloma.